Defunct Company
Total Trials
6
As Lead Sponsor
5
As Collaborator
1
Total Enrollment
104
NCT00057512
Study of Intralesional Injection of M4N in Patients With Refractory Malignant Tumors of the Head and Neck
Phase: Phase 1
Role: Lead Sponsor
Start: Jan 31, 2003
Completion: Dec 31, 2003
NCT00154089
A Pilot Study of EM-1421 for the Treatment of Cervical Intraepithelial Neoplasia
Phase: Phase 1/2
Start: Nov 30, 2004
Completion: Dec 31, 2006
NCT00259818
Dose Escalation Study of EM-1421 for the Treatment of Recurrent or Refractory Solid Tumors
Start: Dec 31, 2005
Completion: Jan 31, 2008
NCT00664586
A Phase 1 Continuous Intravenous Infusion Study of Terameprocol (EM-1421) in Subjects With Refractory Solid Tumors
Start: May 31, 2007
Completion: Jun 30, 2009
NCT00664677
Phase 1 Study of Terameprocol (EM-1421) in Patients With Leukemia
Start: Aug 31, 2007
NCT02575794
Terameprocol in Treating Patients With Recurrent High Grade Glioma
Role: Collaborator
Start: May 3, 2018
Completion: Oct 4, 2023